MASS 908 Devices Inc.
Healthcare$7.81+0.00%OpenMarket Cap: $295.4M
As of 2026-05-26
Valuation
P/E (TTM)
12.96
PEG
0.10
P/B
2.00
P/S
4.76
EV/EBITDA
-11.03
DCF Value
$-9.52
FCF Yield
-3.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
49.0%
Operating Margin
-52.5%
Net Margin
-62.1%
ROE
-25.5%
ROA
-19.2%
ROIC
-20.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $13.4M | 47.7% | $-6.5M | $-12.0M | $— | — |
| Q4 null | $17.4M | 49.9% | $-3.2M | $4.3M | $— | — |
| FY null | $56.2M | 47.7% | $-24.2M | $-36.6M | $— | — |
| Q3 null | $14.0M | 49.3% | $-5.5M | $-14.9M | $— | — |
| Q2 null | $13.0M | 48.9% | $-15.2M | $-13.3M | $— | — |
| Q1 null | $11.8M | 47.0% | $-11.0M | $43.6M | $— | — |
| Q4 null | $18.8M | 48.7% | $-20.3M | $-19.4M | $— | — |
| FY null | $59.6M | 50.2% | $-76.7M | $-72.2M | $— | — |
| Q3 null | $14.5M | 53.6% | $-24.5M | $-29.3M | $— | — |
| Q2 null | $11.5M | 53.8% | $-8.5M | $-12.5M | $— | — |
| Q1 null | $7.4M | 52.4% | $-7.6M | $-10.9M | $— | — |
| Q4 2023 | $14.4M | 50.7% | $-9.7M | $-7.4M | $-0.23 | — |